Heparin

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heparin.php on line 2
Heparin

LE WE PMID CA

Heparin

1127

Heparin

1999 1	Actions of heparin that may affect the malignant process. [10023691] Cancer 85(2): 257-72 (1999)
2005 2	Low-molecular-weight heparin and survival in patients with malignant disease. [16179901] Cancer Control 12 Suppl 1(-): 22-30 (2005)
2008 3	[Pharmacology of heparins and direct anticoagulants]. [19132170] Hamostaseologie 28(5): 400-20 (2008)
2007 4	The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials. [17408406] J Thromb Haemost 5(4): 729-37 (2007)
2000 5	Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells. [11053011] Am J Physiol Lung Cell Mol Physiol 279(5): L779-89 (2000)
2001 6	Mechanism of action and pharmacology of unfractionated heparin. [11451734] Arterioscler Thromb Vasc Biol 21(7): 1094-6 (2001)
1979 7	Heparin: new concepts relevant to clinical use. [371632] Blood 53(4): 525-44 (1979)
2001 8	Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. [11157643] Chest 119(1 Suppl): 64S-94S (2001)
1999 9	Clinical uses of low-molecular-weight heparins. [10334162] Chest 115(5): 1418-23 (1999)
1998 10	Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. [9822059] Chest 114(5 Suppl): 489S-510S (1998)
1992 11	Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. [1327666] Chest 102(4 Suppl): 337S-351S (1992)
2001 12	Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association. [11413093] Circulation 103(24): 2994-3018 (2001)
2008 13	Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin. [18227486] Diabetes Care 31 Suppl 2(-): S202-7 (2008)
2002 14	Perspectives on antithrombotic agents: from unfractionated heparin to new antithrombotics. [12091128] Haematologica 87(7): 757-70 (2002)
2005 15	The heparins: all a nephrologist should know. [16030035] Nephrol Dial Transplant 20(10): 2036-42 (2005)
1999 16	Therapeutic uses of heparinoids in renal disease patients. [10193791] Nephrol Dial Transplant 14(3): 540-3 (1999)
2009 17	Low-molecular-weight heparin in patients with renal insufficiency. [19685350] Swiss Med Wkly 139(31-32): 438-52 (2009)
1982 18	The risks and benefits of heparin therapy. [7090372] West J Med 136(3): 241-2 (1982)
1995 19	Heparin lowers blood pressure: biological and clinical perspectives. [7783398] Kidney Int 47(4): 1017-22 (1995)
2002 20	Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates. [11960179] An Acad Bras Cienc 74(1): 105-12 (2002)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heparin.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Heparin.php on line 92